JCR Pharmaceuticals Co., Ltd.
Notice of Share Buyback
JCR Pharma announced that it completed the share buyback on July 22, 2026. The shares purchased were common shares, and the total amount spent was 98,496,000 yen. The purpose of the buyback was to improve capital efficiency and return value to shareholders.
Key Figures
- Amount of Buyback: 98,496,000 yen
- Type of Shares Purchased: Common shares of the Company
- Buyback Date: 2026-07-22
AI要約
Overview of the Buyback
JCR Pharma completed its share buyback on July 22, 2026. The shares purchased were common shares of the Company, with a total amount of 98,496,000 yen. This buyback was conducted to enhance capital efficiency and improve shareholder returns. Specific details regarding the method and number of shares bought back are not disclosed, but the remaining balance of treasury shares has decreased as a result of the buyback.
Impact on Shareholders and Future Outlook
The share buyback will mitigate dilution of outstanding shares and is expected to enhance shareholder value. As a result of the buyback, the ratio of treasury stock will decrease, and capital efficiency is anticipated to improve. The Company will continue shareholder return policies as part of its capital strategy aiming to maximize shareholder value.
JCR Pharma Co., Ltd.
Company overview · Stock price · Financial data · All IR
